Table 3.

Percentage of IC50 depletion compared to undepleted control in presence of homologous and heterologous competitors at concentration established in the previous set of experiments.

Heterologous Specificity (Percentage of Inhibition Compared to Undepleted Control)
S. Typhimurium			S. Enteritidis
iNTS Primary Human Standard Serum depleted with 10 µg/mL STm GMMA	iNTS Primary Human Standard Serum depleted with 10 µg/mL SEn GMMA	iNTS Primary Human Standard Serum depleted with 10 µg/mL S.flex 3a GMMA	iNTS Primary Human Standard Serum depleted with 10 µg/mL SEn GMMA	iNTS Primary Human Standard Serum depleted with 10 µg/mL STm GMMA	iNTS Primary Human Standard Serum depleted with 10 µg/mL S.flex 3a GMMA
90.1	0	0	88.4	2.2	1.5

STm: S. Typhimurium; SEn: S. Enteritidis; S. flex: S. flexneri.